These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Prostaglandins PGE(2) and PGI(2) promote endothelial barrier enhancement via PKA- and Epac1/Rap1-dependent Rac activation. Birukova AA; Zagranichnaya T; Fu P; Alekseeva E; Chen W; Jacobson JR; Birukov KG Exp Cell Res; 2007 Jul; 313(11):2504-20. PubMed ID: 17493609 [TBL] [Abstract][Full Text] [Related]
5. Regulation by afadin of cyclical activation and inactivation of Rap1, Rac1, and RhoA small G proteins at leading edges of moving NIH3T3 cells. Miyata M; Rikitake Y; Takahashi M; Nagamatsu Y; Yamauchi Y; Ogita H; Hirata K; Takai Y J Biol Chem; 2009 Sep; 284(36):24595-609. PubMed ID: 19589776 [TBL] [Abstract][Full Text] [Related]
6. Role of End Binding Protein-1 in endothelial permeability response to barrier-disruptive and barrier-enhancing agonists. Tian X; Ohmura T; Shah AS; Son S; Tian Y; Birukova AA Cell Signal; 2017 Jan; 29():1-11. PubMed ID: 27667566 [TBL] [Abstract][Full Text] [Related]
7. VE-cadherin trans-interactions modulate Rac activation and enhancement of lung endothelial barrier by iloprost. Birukova AA; Tian Y; Dubrovskyi O; Zebda N; Sarich N; Tian X; Wang Y; Birukov KG J Cell Physiol; 2012 Oct; 227(10):3405-16. PubMed ID: 22213015 [TBL] [Abstract][Full Text] [Related]
8. Epac/Rap and PKA are novel mechanisms of ANP-induced Rac-mediated pulmonary endothelial barrier protection. Birukova AA; Zagranichnaya T; Alekseeva E; Bokoch GM; Birukov KG J Cell Physiol; 2008 Jun; 215(3):715-24. PubMed ID: 18064650 [TBL] [Abstract][Full Text] [Related]